Sensitive and simple bioassay for human tumour necrosis factor-alpha

Area of Science:

• Biochemistry
• Immunology
• Cell Biology

Background:

• Tumor necrosis factor alpha (TNF-alpha) is a critical cytokine involved in inflammation and immune responses.
• Accurate quantification of TNF-alpha is essential for understanding various disease states and evaluating therapeutic interventions.
• Existing bioassays may lack the required sensitivity or specificity for precise TNF-alpha measurement.

Purpose of the Study:

• To develop a simple, sensitive, and specific in vitro bioassay for human TNF-alpha.
• To establish a reliable method for quantifying TNF-alpha in biological samples.
• To characterize the performance of the developed bioassay in terms of sensitivity, linearity, and specificity.

Main Methods:

• Utilized the U937 cell line for the bioassay.
• Incubated U937 cells with actinomycin D (10 ng/ml) to enhance sensitivity.
• Determined the detection limit and log dose-response curve for TNF-alpha.
• Generated and tested highly sensitive U937 subclones.
• Assessed the bioassay's specificity against TNF-beta.

Main Results:

• The bioassay can detect less than 0.6 pg/ml of TNF-alpha.
• The log dose-response curve for TNF-alpha was linear between 0.6-250 pg/ml.
• Highly sensitive U937 subclones detected as little as 0.1 pg/ml of TNF-alpha.
• The bioassay demonstrated specificity, distinguishing TNF-alpha from TNF-beta.

Conclusions:

• A simple, sensitive, and specific in vitro bioassay for human TNF-alpha has been successfully developed.
• The U937 cell-based system, enhanced with actinomycin D, provides reliable quantification of TNF-alpha.
• The developed bioassay is suitable for detecting and quantifying TNF-alpha with high precision and specificity.